Skip to main content
SpringerLink
Log in

Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

The purpose of the present study was to determine whether lymphokine activated killer (LAK) cells were involved in the development of coxsackievirus B3 (CB3) myocarditis in both the acute viremic (Experiment I) and the subacute aviremic (Experiment II) stages. To induce LAK cells, recombinant human interleukin-2 (IL-2) was administered to CB3-infected mice subcutaneously daily, starting on day 0 in Experiment I and on day 7 in Experiment II for 7 days, respectively. The treated groups were compared to infected controls. Splenic lymphocytes of IL-2 treated mice were further cultured in vitro in IL-2 containing medium for 7 days, and LAK cell activity, i.e., cytotoxic activity of the lymphocytes against EL-4 tumor cells and against cultured fetal myocytes, was assayed by51Cr-release method. In Experiment I, histologic scores, myocardial virus titers, and LAK cell activity did not differ significantly between IL-2 treated and untreated groups. In contrast, in Experiment II, there were more cellular infiltration associated with severe necrosis and higher LAK cell activity against EL-4 cells and cultured myocytes in IL-2 treated than in untreated groups. The presence of LAK cells was demonstrated in the subacute stage of murine CB3 myocarditis. Thus, the behavior of LAK cell activity may vary with the course of myocarditis, and enhanced LAK cell activity may be involved in the development of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abelmann WH (1971) Virus and the heart. Circulation 44: 950–956

    Google Scholar 

  2. Chang AE, Hyatt CL, Rosenberg SA (1984) Systemic administration of recombinant human interleukin-2 in mice. J Biol Response Mod 3: 561–568

    Google Scholar 

  3. Dec GW Jr, Palacios IF, Fallon JT, Aretz T, Millis J, Lee DCS, Johnson RA (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. N Engl J Med 312: 885–990

    Google Scholar 

  4. Estrin M, Huber SA (1987) Coxsackievirus B-3 induced myocarditis. Autoimmunity is L3T4+ helper cell and IL-2 independent in Balb/c mice. Am J Pathol 127:335–341

    Google Scholar 

  5. Estrin M, Smith C, Huber SA (1986) Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporine-A treatment. Am J Pathol 125: 244–251

    Google Scholar 

  6. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1832–1841

    Google Scholar 

  7. Huber SA, Job LP, Woodruff JF (1980) Lysis of infected myofibers by coxsackievirus B3-immune T lymphocytes. Am J Pathol 98: 681–694

    Google Scholar 

  8. Huber SA, Lodge PA (1984) Coxsackievirus B3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 116: 21–29

    Google Scholar 

  9. Huber SA, Polgar J, Schultheiss P, Schwimmbeck P (1994) Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 68: 195–206

    Google Scholar 

  10. Kawai C (1971) Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J: 765–768

  11. Kishimoto C, Abelmann WH (1989) Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice. Circulation 79: 1300–1308

    Google Scholar 

  12. Kishimoto C, Abelmann WH (1989) Absence of effects of cyclosporine on myocardial lymphocyte subsets in coxsackievirus B3 myocarditis in the aviremic stage. Circ Res 65: 934–945

    Google Scholar 

  13. Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH (1988) Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation 77: 645–653

    Google Scholar 

  14. Lanier LL, Benike CJ, Phillips JH, Engleman EG (1985) Recombinant interleukin-2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol 134: 794–801

    Google Scholar 

  15. Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC (1983) Characterization of the human receptor for T-cell growth factor. Immunology 80: 6957–6961

    Google Scholar 

  16. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41: 4420–4425

    Google Scholar 

  17. Mule JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225: 1487–1489

    Google Scholar 

  18. Mule JJ, Yang JC, Afreniere RL, Shu S, Rosenberg SA (1987) Identification of cellular mechanisms operated in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol 139: 285–294

    Google Scholar 

  19. Nakamura TY, Yamamoto I, KannoY, Shiba Y, GoshimMa K (1994) Metabolic coupling of glutathione between mouse and quail cardiac myocytes and its protective role against oxidative stress. Circ Res 74: 806–816

    Google Scholar 

  20. Paque RE, Gauntt CJ, Nealon TJ, Trousdale MD (1978) Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol 120: 1672–1678

    Google Scholar 

  21. Ryes M, Lerner AM (1985) Coxsackievirus myocarditis. With special reference to acute and chronic effects. Prog Cardiovasc Dis 27: 373–394

    Google Scholar 

  22. Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA (1984) Lymphokine-activated killer cells. Lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res 44: 1946–1953

    Google Scholar 

  23. Saijo N, Ozaki A, Nakano H, Sakurai M, Takahashi H, Sasaki Y, Hoshi A (1986) In vivo augmentation of the cytotoxity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2). J Cancer Res Clin Oncol 111: 182–186

    Google Scholar 

  24. Weibel ER, Kistler GS, Scherle WF (1966) Practical stereological methods for morphometric cytology. J Cell Biol 30: 23–38

    Google Scholar 

  25. Woodruff JF, Woodruff JJ (1974) Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Immunol 113: 1726–1734

    Google Scholar 

  26. Woodruff JF (1980) Viral myocarditis. A review. Am J Pathol 101: 427–479

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Department of Internal Medicine Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, 930-01, Toyama, Japan

    C. Kishimoto

  2. The Second Department of Internal Medicine and Department of Virology Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, 930-01, Toyama, Japan

    Y. Kuroki, M. Kurokawa & H. Ohiai

Authors
  1. C. Kishimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Kuroki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Kurokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Ohiai
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by research grants from the Conference on Coronary Artery Disease, Japanese Education of Science and Walfare (Nos. 08877110 and 09470164), Kanae Shinyaku Foundation, and Japan Cardiovascular Research Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishimoto, C., Kuroki, Y., Kurokawa, M. et al. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis. Basic Res Cardiol 92, 402–409 (1997). https://doi.org/10.1007/BF00796214

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00796214

Key words

Search

Navigation